Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Different Administration Routes of Dexmedetomidine Combined with Ultrasound-Guided Fascia Iliaca Block on Emergence Agitation After Hip Replacement Surgery

NCT06614010 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

NCT NCT06614010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06614010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Different Administration Routes of Dexmedetomidine Combined with Ultrasound-Guided Fascia Iliaca Block on Emergence Agitation After Hip Replacement Surgery
Lead sponsor
Qianfoshan Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
February 5, 2023
Completion date
December 1, 2025
Enrollment
207 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dexmedetomidine, fascia iliaca block